My Quote Request
No products added yet
6505-00-770-2061
20 Products
NDC43567-0540-01
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
NDC43567-0540-01
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
MFG
MD PHARMACEUTICAL CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE
Related Searches:
NDC00310-0041-10
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
NDC00310-0041-10
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
MFG
ASTRAZENECA LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE
Related Searches:
NDC00364-0575-01
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
NDC00364-0575-01
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
MFG
SCHEIN PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE
Related Searches:
NDC00603-2214-21
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
NDC00603-2214-21
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE
Related Searches:
NDC00781-1488-01
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
NDC00781-1488-01
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505007702061
NSN
6505-00-770-2061
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE
Related Searches:
18A
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505007707344
NSN
6505-00-770-7344
18A
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505007707344
NSN
6505-00-770-7344
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/W DEXTROSE ACTIVE INGREDIENT AND 0.200 PERCENTAGE, W/W SODIUM CHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
413-27
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505007707344
NSN
6505-00-770-7344
413-27
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505007707344
NSN
6505-00-770-7344
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/W DEXTROSE ACTIVE INGREDIENT AND 0.200 PERCENTAGE, W/W SODIUM CHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00003-0122-50
AMPICILLIN CAPSULES,USP
NSN, MFG P/N
6505007708343
NSN
6505-00-770-8343
NDC00003-0122-50
AMPICILLIN CAPSULES,USP
NSN, MFG P/N
6505007708343
NSN
6505-00-770-8343
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMPICILLIN EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMPICILLIN CAPSULES USP 250 MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00093-5145-01
AMPICILLIN CAPSULES,USP
NSN, MFG P/N
6505007708343
NSN
6505-00-770-8343
NDC00093-5145-01
AMPICILLIN CAPSULES,USP
NSN, MFG P/N
6505007708343
NSN
6505-00-770-8343
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMPICILLIN EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMPICILLIN CAPSULES USP 250 MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
POLYCILLIN
AMPICILLIN CAPSULES,USP
NSN, MFG P/N
6505007708343
NSN
6505-00-770-8343
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMPICILLIN EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMPICILLIN CAPSULES USP 250 MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00024-1322-08
NALIDIXIC ACID TABLETS,USP
NSN, MFG P/N
6505007708345
NSN
6505-00-770-8345
NDC00024-1322-08
NALIDIXIC ACID TABLETS,USP
NSN, MFG P/N
6505007708345
NSN
6505-00-770-8345
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NALIDIXIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NEGGRAM
NALIDIXIC ACID TABLETS,USP
NSN, MFG P/N
6505007708345
NSN
6505-00-770-8345
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NALIDIXIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NEGGRAM TABLETS
NALIDIXIC ACID TABLETS,USP
NSN, MFG P/N
6505007708345
NSN
6505-00-770-8345
NEGGRAM TABLETS
NALIDIXIC ACID TABLETS,USP
NSN, MFG P/N
6505007708345
NSN
6505-00-770-8345
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NALIDIXIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DIAL0SE
DIOCTYL SODIUM SULFOSUCCINATE AND CARBOXYMETHYLCELLULOSE SODIUM CAPSULES
NSN, MFG P/N
6505007715272
NSN
6505-00-771-5272
DIAL0SE
DIOCTYL SODIUM SULFOSUCCINATE AND CARBOXYMETHYLCELLULOSE SODIUM CAPSULES
NSN, MFG P/N
6505007715272
NSN
6505-00-771-5272
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:400.000 MILLIGRAMS OF CARBOXYMETHYLCELLULOSE SODIUM ACTIVE INGREDIENTS;100.000 MILLIGRAMS OF DIOCTYL SODIUM SULFOSUCCINATE ACTIVE INGREDIENTS
Related Searches:
MYLANTA
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND SIMETHICONE SUSPENSION
NSN, MFG P/N
6505007719207
NSN
6505-00-771-9207
MYLANTA
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND SIMETHICONE SUSPENSION
NSN, MFG P/N
6505007719207
NSN
6505-00-771-9207
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EACH 5 ML CONTAINS 40 MG ALUMINUMHYDROXIDE,40 MG MAGNESIUM HYDROXIDE,AND 20 MG SIMETHICONE
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES OR 360.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00038-0610-12
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND SIMETHICONE SUSPENSION
NSN, MFG P/N
6505007719207
NSN
6505-00-771-9207
NDC00038-0610-12
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND SIMETHICONE SUSPENSION
NSN, MFG P/N
6505007719207
NSN
6505-00-771-9207
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EACH 5 ML CONTAINS 40 MG ALUMINUMHYDROXIDE,40 MG MAGNESIUM HYDROXIDE,AND 20 MG SIMETHICONE
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES OR 360.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1007-39
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND SIMETHICONE SUSPENSION
NSN, MFG P/N
6505007719207
NSN
6505-00-771-9207
NDC00182-1007-39
ALUMINUM HYDROXIDE GEL,MAGNESIUM HYDROXIDE,AND SIMETHICONE SUSPENSION
NSN, MFG P/N
6505007719207
NSN
6505-00-771-9207
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EACH 5 ML CONTAINS 40 MG ALUMINUMHYDROXIDE,40 MG MAGNESIUM HYDROXIDE,AND 20 MG SIMETHICONE
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES OR 360.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
201-50
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505007719234
NSN
6505-00-771-9234
201-50
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505007719234
NSN
6505-00-771-9234
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITHOUT EPINEPHRINE; MULTIPLE DOSE VIAL
Related Searches:
452390
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505007719234
NSN
6505-00-771-9234
452390
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505007719234
NSN
6505-00-771-9234
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITHOUT EPINEPHRINE; MULTIPLE DOSE VIAL
Related Searches:
NDC00185-0221-26
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505007719234
NSN
6505-00-771-9234
NDC00185-0221-26
LIDOCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505007719234
NSN
6505-00-771-9234
MFG
VITARINE CO INC THE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITHOUT EPINEPHRINE; MULTIPLE DOSE VIAL
